2009 年業績
Ozeki T, Takeuchi M, Suzuki M, Kitamura T, Takayanagi R, Yokoyama H, Yamada Y.
Single nucleotide polymorphisms of 17beta-hydroxysteroid dehydrogenase type 7 gene:mechanism of estramustine-related adverse reactions?
Int J Urol. 2009 16(10): 836-41.
Zhong S, Randhawa PS, Ikegaya H, Chen Q, Zheng HY, Suzuki M, Takeuchi T, Shibuya A,Kitamura T, Yogo Y.
Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, Europeanand Asian populations suggest co-migration of BKV and the human race.
J Gen Virol. 2009 90: 144-52.
Homma Y.
Should an antimuscarinic agent be used for persistent LUTS after treatment with analpha(1)-blocker?
Nat Clin Pract Urol. 2009 6: 66-7.
Zhong S, Jeong B-H, Ikegaya H, Kim Y-S, Xu Yawei, Zhu M, Chao Y, Suzuki M, Kitamura T,
Homma Y, Yogo Y .
Comparison of the distribution patterns of BK polyomavirus lineages among China, Korea andJapan: implications for human migrations in Northeast Asia.
Microbiol Immunol. 2009 53(5): 266-76.
Fujimura T, Takahashi S, Urano T, Liu X, Ogushi T, Muramatsu M,Ouchi Y, Kitamura T,Homma Y, Inoue S.
Estrogen receptor-binding fragment-associated gene 9 expression and its clinical significance inhuman testicular cancer.
Int J Urol. 2009 16: 522-5.

Kurosaki T, Suzuki M, Enomoto Y, Arai T, Sawabe M, Hosoi T, Homma Y, Kitamura T.
Polymorphism of cytochrome P450 2B6 and prostate cancer risk: A significant association in aJapanese population.
Int J Urol 2009 16: 364-8.
Yogo Y, Sugimoto C, Zhong, S, Homma Y.
Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications.
Rev Med Virol 2009 19: 185-99.
Tsurumaki Y, Kume H, Homma Y.
Late recurrence of uterine endometrioid carcinoma in the upper urinary tract.
Arch Gynecol Obstet 2009 280(4): 631-2.
Kumagai J, Urano T, Ogushi T, Takahashi S, Horie-Inoue K, Fujimura T, Azuma K, Muramatsu
M, Ouchi Y, Kitamura T, Inoue S.
EBAG9 is a tumor-promoting and prognostic factor for bladder cancer.
Int J Cancer 2009 124: 799-805.
Takayama K, Tsutsumi S, Suzuki T, Horie-Inoue K, Ikeda K, Kaneshiro K, Fujimura T, Kumagai
J, Urano T, Sakaki Y, Shirahige K, Sasano H, Takahashi S, Kitamura T, Ouchi Y, Aburatani H,Inoue S.
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer
growth.
Cancer Res. 2009 69: 137-42.
Fujimura T, Takahashi S, Urano T, Kumagai J, Murata T, Takayama K, Ogushi T, Horie-Inoue K,
Ouchi Y, Kitamura T, Muramatsu M, Homma Y, Inoue S.
Expression of Cytochrome P450 3A4 and Its Clinical Significance in Human Prostate Cancer.
Urology 2009 74(2): 391-7.
Gotoh M, Homma Y, Funahashi Y, Matsukawa Y, Kato M.
Psychometric validation of the Japanese version of the International Consultation on
Incontinence Questionnaire-Short Form.
Int J Urol. 2009 16: 303-6.

Kume H, Teramoto S, Kitamura T.
Metachronous bilateral renal cell carcinoma with an interval of more than 10 years.
Int Urol Nephrol. 2009 41: 843-6.
Liu M, Kurosaki T, Suzuki M, Enomoto Y, Nishimatsu H, Arai T, Sawabe M, Hosoi T, Homma Y,Kitamura T.
Significance of Common Variants on Human Chromosome 8q24 in Relation to the Risk ofProstate Cancer in Native Japanese Men.
BMC Genet. 2009 10: 37.
Homma Y, Gotoh M.
Symptom severity and patient perceptions in overactive bladder: how are they related?
BJU Int. 2009 104: 968-72
Homma Y, Yamaguchi O, Imidafenacin Study Group.
A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic
agent imidafenacin in Japanese patients with overactive bladder.
Int J Urol. 2009 16: 499-506.
Fukuhara H, Homma Y, Todo T.
Oncolytic virus therapy for prostate cancer.
Int J Urol. 2009 17(1): 20-30.
Homma Y, Araki I, Igawa Y, Ozono S, Gotoh M, Yamanishi T, Yokoyama O, Yoshida M;
Japanese Society of Neurogenic Bladder.
Clinical guideline for male lower urinary tract symptoms.
Int J Urol. 2009 16(10): 775-90.
Matsumoto S, Ishikawa A, Kume H, Takeuchi T, Homma Y.
Near infrared spectroscopy study of the central nervous activity during artificial changes inbladder sensation in men.
Int J Urol. 2009 16(9): 760-4.
Homma Y, Ueda T, Tomoe H, Lin AT, Kuo HC, Lee MH, Lee JG, Kim DY, Lee KS; Interstitial
cystitis guideline committee.
Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome.
Int J Urol. 2009 16(7): 597-615.

Fujimura T, Takahashi S, Kume H, Takeuchi T; Clinical Study Group of Tokyo University
Affiliated Hospitals, Kitamura T, Homma Y.
Cancer-related pain and quality of life in prostate cancer patients: assessment using the
Functional Assessment of Prostate Cancer Therapy.
Int J Urol. 2009 16(5): 522-5.
Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, Obara K, Gotoh M,Igawa Y, Seki N, Yoshida M; Neurogenic Bladder Society.
Clinical guidelines for overactive bladder.
Int J Urol. 2009 16(2): 126-42.
Homma Y, Ueda T, Ito T, Takei M, Tomoe H.
Japanese guideline for diagnosis and treatment of interstitial cystitis.
Int J Urol. 2009 16(1): 4-16.
Kim MS,Kondo T,Takada I,Youn MY, Yamamoto Y,Takahashi S,Matsumoto T,Fujiyama
S,Shirode Y,Yamaoka I,Kitagawa H,Takeyama K,Shibuya H,Ohtake F,Kato S.
DNA demethylation in hormone-induced transcriptional derepression.
Nature. 2009; 461: 1007-12
Nakagawa T, Kanai Y, Komiyama M, Fujimoto H, Kakizoe T.
Characteristics of Prostate Cancers Found in Specimens Removed by Radical
Cystoprostatectomy for Bladder Cancer and Their Relationship with Serum Prostate-Specific
Antigen Level.
Cancer Sci.

2009 100: 1880-4

Azuma, T., G. Zhu, H. Xu, A. C. Rietz, C. G. Drake, E. L. Matteson, and L. Chen.
Potential role of decoy b7-h4 in the pathogenesis of rheumatoid arthritis: a mouse model
informed by clinical data.
PLoS Med. 2009 6: e1000166.
Zhu G, Augustine MM, Azuma T, Luo L, Yao S, Anand S, Rietz AC, Huang J, Xu H, Flies AS,Flies SJ, Tamada K, Colonna M, van Deursen JM, Chen L.
B7-H4-deficient mice display augmented neutrophil-mediated innate immunity.
Blood. 2009 113(8): 1759-67.

Christensen NB, Kume H, Autorino R.
How to write titles and abstracts for readers.
Int J Urol. 2009 16(1): 2-3.
Kume H, Christensen NB.
Report of the International Journal of Urology Editorial Board meeting 2009 in Okayama.
Int J Urol. 2009 16(7): 594-5.